148
Views
4
CrossRef citations to date
0
Altmetric
Original Research

Efficacy of 0.05% epinastine and 0.1% olopatadine for allergic conjunctivitis as seasonal and preseasonal treatment

, &
Pages 1747-1753 | Published online: 27 Sep 2017

References

  • BieloryBPShahSPO’BrienTPPerezVLBieloryLEmerging therapeutics for ocular surface diseaseCurr Opin Allergy Clin Immunol201616547748627585059
  • La RosaMLionettiEReibaldiMAllergic conjunctivitis: a comprehensive review of the literatureItal J Pediatr20131418
  • SinghKAxelrodSBieloryLThe epidemiology of ocular and nasal allergy in the United States, 1988–1999J Allergy Clin Immunol2010126477878320920769
  • OkudaMEpidemiology of Japanese cedar pollinosis throughout JapanAnn Allergy Asthma Immunol20039128829614533662
  • YamadaTSaitoHFujiedaSPresent state of Japanese cedar pollinosis: the national affictionJ Allergy Clin Immunol20141333632.e5639.e524361081
  • LeursRChurchMKTaglialatelaMH1-antihistamines: inverse agonism, anti-inflammatory actions and cardiac effectsClin Exp Allergy200232448949811972592
  • MizuguchiHOnoSHattoriMUsefulness of HeLa cells evaluate inverse agonistic activity of antihistaminesInt Immunopharmacol200315539543
  • BakkerRAWielandKTimmermanHLeursRConsecutive activity of the histamine H(1) receptor reveals inverse agonism of histamine H(1) receptor antagonistEur J Pharmacol20003871R5R710633171
  • DasAKYoshimuraSMishimaRStimulation of histamine H1 receptor up-regulates histamine H1 receptor itself through activation of receptor gene transcriptionJ Pharmacol Sci200710337438217409634
  • TrattlerWBLuchsJMajmudarPElestat (epinastin HCl ophthalmic solution 0.05%) as a therapeutic for allergic conjunctivitisInt Ophthalmol Clin20064646879917060795
  • FujishimaHOhashiYTakamuraEEfficacy of epinastine hydrochloride ophthalmic solution in allergic conjunctivitis by conjunctival cedar pollen allergen challengeAnn Allergy Asthem Immunol20141134476481
  • FukushimaAEbiharaNEfficacy of olopatadine versus epinastine for treating allergic conjunctivitis caused by Japanese cedar pollen: a double-blind randomized controlled trialAdv Ther2014311045105825269854
  • NakagawaYOohashiYTakamuraEFujishimaHSafety and efficacy of long-term treatment with 0.05% epinastine ophthalmic solution for allergic conjunctivitisAtarashii Ganka201431197104
  • OgisoTTakanoYKawashimaSFujishimaHClinical efficacy of olopatadine hydrochloride ophthalmic solution for allergic conjunctivitis: comparison with combination therapy using anti-histamic and mast cell stabilizer ophthalmic solutionsAtarashii Ganka2008251115531556
  • EbiharaNPreventive effect of olopatadine ophthalmic solution in seasonal allergic conjunctivitisAtarashii Ganka2007241115231525
  • ShimuraMYasudaKMiyazawaTPre-seasonal treatment with topical olopatadine suppresses the clinical symptoms of seasonal allergic conjunctivitisAm J Ophthalmol2011151469770221257151
  • MiyataKAmanoSSawadaMNishidaTA novel grading method for superficial punctate keratopathy magnitude and its correlation with corneal permeabilityArch Ophthalmol2003121111537153914609908